References
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136(4):1134–44.
Deoliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, et al. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011;53(4):1363–71.
Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98(12):873–5.
Lee YT, Geer DA. Primary liver cancer: pattern of metastasis. J Surg Oncol. 1987;36(1):26–31.
Kwon OS, Jun DW, Kim SH, Chung MY, Kim NI, Song MH, et al. Distant skeletal muscle metastasis from intrahepatic cholangiocarcinoma presenting as Budd–Chiari syndrome. World J Gastroenterol. 2007;13(22):3141–3.
Law JK, Davis J, Buckley A, Salh B. Intrahepatic cholangiocarcinoma presenting as the Budd–Chiari syndrome: a case report and literature review. Can J Gastroenterol. 2005;19(12):723–8.
Kwon BJ, Rhim H, Kim YS, Koh BH, Cho OK. Peripheral cholangiocarcinoma with extensive tumor thrombi in the portal venous system: case report. Abdom Imaging. 2000;25(6):615–7.
Shimoda M, Iso Y, Tomita S, Fujimori T, Murakami K, Sawada T, et al. Middle bile duct cancer with portal vein tumor thrombus. World J Surg Oncol. 2008;6:48.
Lucidi V, Van Laethem JL, Serste T, Gelin M, Donckier V. Peripheral cholangiocarcinoma with endoluminal tumor thrombus in main bile duct mimicking a Klatskin tumor. J Gastrointest Surg. 2008;12(6):1149–50.
Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, et al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology. 2009;50(3):791–8.
Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98(8):1689–700.
Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous thromboembolism and cancer. Lancet. 1998;351(9109):1077–80.
Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med. 1998;338(17):1169–73.
Hettiarachchi RJ, Lok J, Prins MH, Buller HR, Prandoni P. Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis. Cancer. 1998;83(1):180–5.
Mandala M, Falanga A, Piccioli A, Prandoni P, Pogliani EM, Labianca R, et al. Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM). Crit Rev Oncol Hematol. 2006;59(3):194–204.
Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349(2):146–53.
Hull RD, Pineo GF, Brant RF, Mah AF, Burke N, Dear R, et al. Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med. 2006;119(12):1062–72.
Deitcher SR, Kessler CM, Merli G, Rigas JR, Lyons RM, Fareed J. Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period. Clin Appl Thromb Hemost. 2006;12(4):389–96.
Khorana AA, Streiff MB, Farge D, Mandala M, Debourdeau P, Cajfinger F, et al. Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol. 2009;27(29):4919–26.
Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest. 2003;124(3 Suppl):58S–68S.
Lazo-Langner A, Goss GD, Spaans JN, Rodger MA. The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials. J Thromb Haemost. 2007;5(4):729–37.
Conflict of Interest
The authors declare that they have no conflict of interest or financial disclosures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gnanapandithan, K., Allaparthi, S., Ukena, T. et al. Cholangiocarcinoma: Another Masquerader in the Making?. J Gastrointest Canc 45 (Suppl 1), 14–17 (2014). https://doi.org/10.1007/s12029-013-9518-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-013-9518-2